Crude oil benchmarks plunged over 7%, with Brent near $66 and WTI around $62, as President Trump's comments eased fears of a U.S.-Iran conflict and a sell-off in metals markets spilled over. Analysts suggest the drop reflects a rapid unwinding of risk premiums rather than a fundamental change in supply dynamics.
Despite posting robust year-over-year growth, Brown & Brown's Q4 revenue miss triggered a sharp sell-off. The earnings call revealed deeper pressures, from integration challenges and talent poaching to market normalization, setting the stage for a pivotal 2024.
Meta Platforms' shares soared following a robust Q4 earnings beat and aggressive AI investment plans. While core advertising thrives, the company's massive capital expenditure hike raises questions about long-term payoff and competitive positioning.
With Bob Iger's anticipated departure, Disney's board prepares to select a new CEO amid investor scrutiny over the company's strategic direction and recent stock performance. The decision is poised to shape priorities for its streaming services, theme parks, and content slate.
Shares of electrical connection specialist nVent Electric have surged nearly 80% in the past year, prompting investors to question whether the rally has outpaced the company's fundamental value. A deep dive into valuation metrics suggests caution may be warranted.
As Europe's markets navigate a fragile recovery, investors are turning to dividend-paying stocks for income and resilience. We examine three companies offering attractive yields, weighing their potential against underlying financial risks.
As voters from Japan to Brazil head to the polls in a packed electoral calendar, investors brace for potential market volatility. The outcomes could redefine fiscal policies, international alliances, and economic trajectories in a world already navigating U.S. monetary uncertainty and geopolitical strife.
Shares of Tyson Foods (TSN) have climbed over 12% in the past month, reigniting discussions on Wall Street about the meatpacking giant's valuation. While some analysts see room for further growth, others caution that recent gains may have outpaced fundamentals.
Global markets stumbled on Monday, with Asian shares and U.S. futures declining sharply. The sell-off was led by a significant pullback in South Korean tech stocks amid renewed concerns over an AI sector bubble, while oil prices dropped over $2 per barrel.
Prominent Venezuelan human rights defender Javier Tarazona has been released after over four years in detention on charges widely condemned as politically motivated, as the government announces a new amnesty law and the U.S. re-engages diplomatically.
Costa Ricans cast ballots Sunday in an election defined by soaring narco-violence, with ruling party candidate Laura Fernandez, promising a Bukele-style crackdown, favored to win. The vote signals a potential rightward shift and constitutional showdown in a nation struggling with its transformation into a major drug trafficking hub.
Venezuela has released more than 30 individuals classified as political prisoners, according to a leading rights organization. The move follows the government's announcement of a proposed amnesty law and comes amid mounting international pressure and domestic calls for faster action.
The killing of pregnant EMT Melissa Lamesch in a staged house fire has led to murder charges against Matthew Plote, a fellow first responder who allegedly concealed her pregnancy. The case has sent shockwaves through Illinois' tight-knit emergency services community.
ArcBest (ARCB) presents a complex valuation picture, with a discounted cash flow model suggesting deep undervaluation while its P/E ratio signals potential overpricing. As the stock hovers around $90, investors weigh conflicting signals against a backdrop of shifting freight demand and industry consolidation.
After a relatively subdued 2025, Wall Street's projections for Nvidia's revenue growth remain robust. Analysts are debating whether the chipmaker's current valuation sets the stage for a significant rebound or a period of consolidation.
Crude futures retreated sharply on Monday after weekend comments from U.S. President Donald Trump suggested diplomatic engagement with Iran, easing fears of a military confrontation that had recently buoyed markets.
Glaukos Corporation's iDose TR glaucoma therapy receives a key FDA labeling update, permitting repeat administration. While the news bolsters the company's growth narrative, analysts are divided on whether its current stock price already reflects future potential amid rich valuation metrics.
With shares of the global sustainability leader up nearly 7x over three years, investors are grappling with a critical question: has the market run too far ahead of fundamentals? A deep dive into valuation metrics suggests caution may be warranted.
BeOne Medicines (ONC) presents a complex picture for investors, with recent short-term volatility contrasting sharply with strong long-term returns. As the stock trades around $340, analysts debate whether its current price fully reflects the ambitious growth narrative in its oncology pipeline.
Spectrum Brands Holdings (SPB) has seen its share price swing between short-term gains and longer-term declines, raising questions about its true valuation. With a current price of $63.71 sitting below analyst targets, investors are weighing operational improvements against macroeconomic risks.
